Edesa Biotech (EDSA) Other Non-Current Liabilities (2013 - 2023)
Edesa Biotech (EDSA) reported Other Non-Current Liabilities of $44,340 for fiscal Q2 2023 (quarter ended Mar 31, 2023), down 7.6% from $47,970 a year earlier but up 0.1% from the prior quarter.
Powered by 
Analysis
Edesa Biotech (EDSA) Other Non-Current Liabilities (2013 - 2023) Analysis & Trends
At the end of FY2022 (ended Sep 30, 2022), Edesa Biotech posted Other Non-Current Liabilities of $43,662, down 7.5% from FY2021.
- By fiscal year, Other Non-Current Liabilities came in at $47,202 in FY2021 (+57.7%) and $29,928 in FY2020.
- Five-year quarterly Other Non-Current Liabilities spans a low of $29,320 in fiscal Q3 2020 and a high of $48,396 in fiscal Q3 2021.
- Year over year, Other Non-Current Liabilities has now declined in each of the last four quarters, with growth averaging 12.3% over the last eight quarters.
- The high point for year-over-year Other Non-Current Liabilities in five years was fiscal Q3 2021 (growth of 65.1%); the low point was fiscal Q2 2023 (a decline of 7.6%).
- Per Business Quant data, the three fiscal quarters before Q2 2023 came in at $44,280 (Q1 2023), $43,662 (Q4 2022) and $46,536 (Q3 2022).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn |
| 10 | Edesa Biotech | 26.08 Mn | -19.46 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2023 | 44,340.00 |
| Dec 31, 2022 | 44,280.00 |
| Sep 30, 2022 | 43,662.00 |
| Jun 30, 2022 | 46,536.00 |
| Mar 31, 2022 | 47,970.00 |
| Dec 31, 2021 | 47,244.00 |
| Sep 30, 2021 | 47,202.00 |
| Jun 30, 2021 | 48,396.00 |
| Mar 31, 2021 | 47,646.00 |
| Dec 31, 2020 | 47,082.00 |
| Sep 30, 2020 | 29,928.00 |
| Jun 30, 2020 | 29,320.00 |
| Aug 31, 2014 | 5.35 Mn |
| Aug 31, 2013 | 6.84 Mn |
API Access
Edesa Biotech Other Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=EDSA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-liabilities", "ticker": "EDSA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=EDSA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();